Abstract
Natural products have been found to be useful in the treatment of several diseases across the ages. In this article, we review the use of natural products, obtained from dietary sources, as lead compounds in developing novel therapeutic agents. These compounds have shown tremendous promise in the prevention and as well as treatment of a variety of chronic ailments. In addition, to being patentable and biocompatible, these compounds are a rich source of novel scaffolds to invigorate the pipelines of the pharmaceutical industry. In this communication, we also focus on studies which show how natural products have proved useful as lead compounds in virtual screening and structure-based drug design programs. Natural dietary constituents, such as resveratrol, curcumin and caffeine as well as other compounds, are discussed to illustrate this approach.
Keywords: Caffeine, chemoprevention, curcumin, genistein, istradefylline, resveratrol, lead compounds, biocompatible, novel scaffolds, virtual screening, cancer, phytochemicals
Current Pharmaceutical Biotechnology
Title: Natural Products of Dietary Origin as Lead Compounds in Virtual Screening and Drug Design
Volume: 13 Issue: 1
Author(s): Werner J. Geldenhuys, Anupam Bishayee, Altaf S. Darvesh and Richard T. Carroll
Affiliation:
Keywords: Caffeine, chemoprevention, curcumin, genistein, istradefylline, resveratrol, lead compounds, biocompatible, novel scaffolds, virtual screening, cancer, phytochemicals
Abstract: Natural products have been found to be useful in the treatment of several diseases across the ages. In this article, we review the use of natural products, obtained from dietary sources, as lead compounds in developing novel therapeutic agents. These compounds have shown tremendous promise in the prevention and as well as treatment of a variety of chronic ailments. In addition, to being patentable and biocompatible, these compounds are a rich source of novel scaffolds to invigorate the pipelines of the pharmaceutical industry. In this communication, we also focus on studies which show how natural products have proved useful as lead compounds in virtual screening and structure-based drug design programs. Natural dietary constituents, such as resveratrol, curcumin and caffeine as well as other compounds, are discussed to illustrate this approach.
Export Options
About this article
Cite this article as:
J. Geldenhuys Werner, Bishayee Anupam, S. Darvesh Altaf and T. Carroll Richard, Natural Products of Dietary Origin as Lead Compounds in Virtual Screening and Drug Design, Current Pharmaceutical Biotechnology 2012; 13 (1) . https://dx.doi.org/10.2174/138920112798868548
DOI https://dx.doi.org/10.2174/138920112798868548 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biologic Agents in the Treatment of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery Selenium Deficiency in Soils and Crops and its Impact on Animal and Human Health
Current Nutrition & Food Science Cardiomyopathy of Pregnancy
Current Women`s Health Reviews Meet Our Editorial Board Member
Current Vascular Pharmacology Ginger and Heart Health: From Mechanisms to Therapeutics
Current Molecular Pharmacology Endothelium and Oxidative Stress: The Pandora's Box of Cerebral (and Non-Only) Small Vessel Disease?
Current Molecular Medicine Treatment of Obesity: Should We Target the Individual or Society?
Current Pharmaceutical Design Different Concepts of Drug Delivery in Disease Entities
Mini-Reviews in Medicinal Chemistry Editorial: [Hot Topic: Pharmaceutical Kinetics and Toxicological Effects of Nanosystems and Nanomaterials for Biomedical Applications]
Current Drug Metabolism Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
Current Neuropharmacology The “Aged Garlic Extract” (AGE) and One of its Active Ingredients S-Allyl-LCysteine (SAC) as Potential Preventive and Therapeutic Agents for Alzheimer's Disease (AD)
Current Medicinal Chemistry Editorial (A New Era for Medicinal Chemistry)
Mini-Reviews in Medicinal Chemistry Nigella Sativa Improve Redox Homeostasis in Heart and Aorta of Diabetic Rat
Current Nutrition & Food Science Restless Legs Syndrome in Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Clinical, Molecular- and Cytogenetic Analysis of a Case of Severe Radio- Sensitivity
Current Genomics Vascular Endothelin and Hypertension - From Receptors to Medicine
Current Hypertension Reviews Antivitamin K Drugs in Stroke Prevention
Current Vascular Pharmacology Gender Differences in Non-Obstructive Coronary Artery Disease
Current Pharmaceutical Design Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases
Current Pharmaceutical Design Clinical Impacts in Cardiovascular Molecular Imaging: the Example of Cardiac Sympathetic Imaging in Heart Failure
Current Medical Imaging